Aller au contenu principal
2026 article

Formulation And Optimization Of A Transdermal Patch For Delivery Of Anti-Anxiety Phytoconstituents

0Citations signalées — pas une note de qualité
7Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

Transdermal drug delivery systems have gained significant attention as an effective alternative to oral therapy due to their ability to bypass first-pass metabolism and provide controlled drug release. The present research focuses on the formulation and optimization of a transdermal patch containing anti-anxiety phytoconstituents extracted from medicinal plants traditionally used in the management of anxiety disorders. The selected phytoconstituents were characterized for compatibility with polymeric excipients prior to formulation. Transdermal patches were prepared using the solvent casting method with varying concentrations of polymers, plasticizers, and permeation enhancers. Optimization was carried out using a systematic experimental design to achieve desirable physicochemical properties. The prepared patches were evaluated for thickness, weight variation, folding endurance, moisture content, drug content uniformity, and in vitro drug release. Ex vivo permeation studies were performed using suitable animal skin to assess permeation behavior1 . The optimized formulation demonstrated satisfactory mechanical strength, uniform drug distribution, and sustained release of phytoconstituents over an extended period. The findings suggest that the developed transdermal patch offers a promising, non-invasive, and patient-friendly approach for the delivery of anti-anxiety phytoconstituents, potentially improving therapeutic efficacy and patient compliance

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Formulation And Optimization Of A Transdermal Patch For Delivery Of Anti-Anxiety Phytoconstituents
Date Crossref
14/04/2026
Éditeur
Dr. Yashwant Research Labs Pvt. Ltd.
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Advancements in Transdermal Drug DeliveryDrug Solubulity and Delivery SystemsMicroencapsulation and Drying Processes

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.